Reported Consolidated quarterly numbers for ANG Lifesciences India are:
Net Sales at Rs 24.73 crore in December 2024 up 33.34% from Rs. 18.55 crore in December 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 5.19 crore in December 2024 up 12.48% from Rs. 5.93 crore in December 2023.
EBITDA stands negative at Rs. 2.42 crore in December 2024 down 24.74% from Rs. 1.94 crore in December 2023.
ANG Lifescience shares closed at 33.21 on March 03, 2025 (BSE) and has given -31.48% returns over the last 6 months and -46.44% over the last 12 months.
Story continues below Advertisement
| ANG Lifesciences India | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Dec'24 | Sep'24 | Dec'23 | | Net Sales/Income from operations | 24.73 | 32.88 | 18.55 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 24.73 | 32.88 | 18.55 | | EXPENDITURE | | Consumption of Raw Materials | 16.90 | 24.13 | 13.58 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.85 | -2.68 | -2.00 | | Power & Fuel | -- | -- | -- | | Employees Cost | 4.44 | 4.58 | 4.49 | | Depreciation | 1.96 | 1.74 | 1.91 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 6.38 | 4.57 | 4.39 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -4.11 | 0.55 | -3.82 | | Other Income | -0.27 | 0.35 | -0.03 | | P/L Before Int., Excpt. Items & Tax | -4.38 | 0.89 | -3.85 | | Interest | 2.00 | 2.18 | 2.51 | | P/L Before Exceptional Items & Tax | -6.38 | -1.29 | -6.37 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -6.38 | -1.29 | -6.37 | | Tax | -1.19 | 0.80 | -0.44 | | P/L After Tax from Ordinary Activities | -5.19 | -2.09 | -5.93 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -5.19 | -2.09 | -5.93 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -5.19 | -2.09 | -5.93 | | Equity Share Capital | 13.06 | 13.06 | 13.06 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -3.98 | -1.53 | -4.53 | | Diluted EPS | -3.98 | -1.53 | -4.53 | | EPS After Extra Ordinary | | Basic EPS | -3.98 | -1.53 | -4.53 | | Diluted EPS | -3.98 | -1.53 | -4.53 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
